Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 1/20 | 0.77 |
| ▸ | TSHR | P16473 | 2/20 | 0.59 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | GAA | P10253 | 1/20 | 0.59 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.59 |
| ▸ | HTT | P42858 | 1/20 | 0.59 |
| ▸ | CES2 | O00748 | 1/20 | 0.56 |
| ▸ | CES1 | P23141 | 1/20 | 0.56 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.52 |
| ▸ | CNR2 | P34972 | 1/20 | 0.51 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.50 |
| ▸ | PAM | P19021 | 2/20 | 0.48 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.48 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenylacetic Acid SCHEMBL7322793 | 0.88 | AKR1B1 (0.90) | AKR1B1TSHRABCC4LMNAGAA | |
| Phenylacetic Acid SCHEMBL27758886 | 0.88 | AKR1B1 (1.00) | AKR1B1TSHRABCC4LMNAGAA | |
| Phenylacetic Acid SCHEMBL1459 | 0.88 | AKR1B1 (1.00) | AKR1B1TSHRABCC4LMNAGAA | |
| Phenylacetic Acid SCHEMBL9449909 | 0.88 | AKR1B1 (1.00) | AKR1B1TSHRABCC4LMNAGAA | |
| Phenylacetic Acid SCHEMBL1330777 | 0.88 | AKR1B1 (1.00) | AKR1B1TSHRABCC4LMNAGAA | |
| Phenylacetic Acid SCHEMBL28242469 | 0.88 | AKR1B1 (1.00) | AKR1B1TSHRABCC4LMNAGAA | |
| Phenylacetic Acid SCHEMBL13618842 | 0.88 | AKR1B1 (1.00) | AKR1B1TSHRABCC4LMNAGAA | |
| Phenylacetic Acid SCHEMBL7556535 | 0.86 | AKR1B1 (0.63) | AKR1B1TSHRABCC4LMNAGAA | |
| SCHEMBL39103 | 0.86 | CA2 (0.62) | AKR1B1TSHRABCC4LMNAGAA | |
| SCHEMBL1331730 | 0.86 | CA2 (0.62) | AKR1B1TSHRABCC4LMNAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200181086-A1 | 1-CYANO-PYRROLIDINE COMPOUNDS AS USP30 INHIBITORS | MISSION THERAPEUTICS LIMITED (GB) | 2020-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200181086-A1 | 1-CYANO-PYRROLIDINE COMPOUNDS AS USP30 INHIBITORS | USP30, USP20, USP10 | AKR1B1 1816/4885TSHR 3934/4885ABCC4 2436/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.